Shares in Generex Biotechnology Corporation (OTC: GNBT), a development stage company engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological disease, are soaring in trading today. At last check, GNBT shares were trading 22.51% higher at $0.0430 on volume of 4.04 million. The stock hit an intra-day [...]
Recent Comments